Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Smith & Nephew touts 1st-use of Navio robotic-assisted knee system
A New York hospital is the 1st to use Smith & Nephew new robotics-assisted total knee replacement procedure following its recent 510(k) clearance from the FDA.
The surgery took place at the John T. Mather Memorial Hospital in Port Jefferson, N.Y., involving Smith & Nephew’s handheld robotics-assisted Navio platform, and its Journey II BCS knee implant. Read more
4. Hologic posts beat-and-raise 3rd quarter earnings
Hologic today released 3rd quarter earnings that topped analyst’s expectations, raising its outlook for the rest of the year in response.
The Marlborough, Mass.-based company reported profits of $84.8 million, or 30¢ per share, on revenue of $717.4 million for the 3 months ended June 25. That’s a huge uptick for Hologic, seeing a 188% bottom-line gain as sales grew 3.4% compared with the same quarter from 2015. Read more
3. Derma Sciences acquires BioD for $21.3m
Derma Sciences said today it is buying regenerative medicine developer BioD for $21.3 million up front, with the possibility of an additional $56.5 million.
The deal between Princeton, N.J.-based Derma Sciences and Cordova, Tenn.-based BioD includes regulatory milestone payments up to $30 million and earn outs based on net sales growth of up to $26.5 million. Read more
2. Zimmer Biomet shares lift after reporting big gains in sales
Zimmer Biomet shares have risen nearly 5% after releasing solid 2nd quarter earnings, beating the street on earnings per share and seeing sales swell 65.6% compared to last year.
The Warsaw, Ind.-based company reported losses of $31.3 million, or 16¢ per share, on sales of $1.9 billion for the 3 months ended June 30. Read more
1. Boston Scientific Q2 meets the street as sales grow
Boston Scientific today reported 2nd quarter earnings that met the Street’s expectations and saw overall sales grow over 15% from last year, sending shares up lightly in pre-market trading.
The Marlborough, Mass.-based company reported losses of $207 million, or 15¢ per share, on sales of $2.1 billion for the 3 months ended June 30. Read more
The post MassDevice.com +5 | The top 5 medtech stories for July 28, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2aNxNre
Cap comentari:
Publica un comentari a l'entrada